BioSpace News Archive

Calithera Biosciences, Inc. announced the pricing of its previously announced underwritten public offering and is selling 5,000,000 shares of its common stock at a price to the public of $6.25 per share.

Transparency Market Research has published a new report on the photodynamic therapy market for the Forecast period of 2019 - 2027.

The global gynecological devices market is marked by a high degree of fragmentation due to the presence of several large and small manufacturers, reports Transparency Market Research in a new business intelligence study.

The global Parkinson’s disease therapeutics market was valued at US$ 2.18 Bn in 2016 and is projected to register a cumulative annual growth rate of more than 10.9% from 2017 to 2025, according to a new report titled “Parkinson’s Disease Threapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025” published by Transparency Market Research

Considering how common viral conjunctivitis is, the demand for medications to speed up its recovery is high.

A recent report by TMR Research, titled, “Lung Infections Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025,” finds that one of the main reasons the market is rising is because of the reduction in time for approval of new and more effective treatment drugs and therapies.

Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless cancers and autoimmune diseases, announced that it is relaunching as Byondis.

Themis announced that Iain Dukes, MA, DPhil, currently Venture Partner at OrbiMed Advisors LLC, has been appointed as an independent director to the Company’s Supervisory Board.

Co-Diagnostics, Inc. announced that OralDNA® Labs, a CLIA-certified laboratory, has recently validated a COVID-19 PCR test based on the Company’s patented CoPrimer™ technology for use with saline oral rinse samples, and has notified the FDA of their intent to use the validated test in their CAP accredited high-complexity laboratory.

IRADIMED CORPORATION announced that the Company will release its 2020 first quarter financial results before the market opens on Thursday, April 30th.